Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study by Shengyuan Jiao MS, Li Guo PhD, Fei Da PhD, Qiaohui Gao MS, Zhenghua Ren MS, Jianyu Wang MS, Quanwei Fu PhD, Junye Liu PhD

“…Methods: We retrospectively analyzed data extracted from the Surveillance, Epidemiology, and End Results (SEER) database and a total of 1856 patients from 18 cancer registries across the United States diagnosed between 2010 and 2015 were included. …”
Get full text

Global incidence, mortality and temporal trends of cancer in children: A joinpoint regression analysis by Junjie Huang, Sze Chai Chan, Chun Ho Ngai, Veeleah Lok, Lin Zhang, Don Eliseo Lucero‐Prisno III, Wanghong Xu, Zhi‐Jie Zheng, Edmar Elcarte, Mellissa Withers, Martin C. S. Wong, NCD Global Health Research Group, Association of Pacific Rim Universities (APRU)

“…Abstract Background/Methods The Cancer Incidence in Five Continents Time Trends, Nordic Cancer Registries, Surveillance, Epidemiology and End Results, WHO Mortality databases were assessed to extract the Age‐Standardised Rates (ASR) of cancer incidence and mortality among children aged 0–14 years old. …”
Get full text

Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study by Geertruida H De Bock, Delphine Maucort-Boulch, Clémence Leyrat, Amélie Anota, Stephane Dalle, Susana Puig, Marie Préau, Mohammad S Jalali, Marie-Jose Kersten, Martijn GH van Oijen, Mathieu Fauvernier, Petra C. Vinke, Marc Combalia, Anne Mea Spanjaart, Maria Gomes da Silva, Aurore Fouda Essongue, Aurélie Rabier, Myriam Pannard, Amal Elgammal, Mike Papazoglou, Mohand-Said Hacid, Catherine Rioufol, Erick Suazo-Zepeda, Ananya Malhotra, Emmanuel Coquery, Elsa Coz

“…We aim to include about 1800 adult patients with cancer treated with immunotherapy in a specifically recruited prospective cohort, and to additionally obtain data from historical real-world databases (ie, databiobanks) and medical administrative registries (ie, national cancer registries) in which relevant data regarding other adult patients with cancer treated with immunotherapy has already been stored. …”
Get full text

HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank by Luke C Pilling, David Melzer, Janice L Atkins, Mitchell R Lucas, Jeremy D Shearman

“…We estimated p.C282Y and p.H63D variant cumulative incidence of multiple clinical outcomes in a large community cohort.Design Prospective cohort study.Setting 22 assessment centres across England, Scotland, and Wales in the UK Biobank (2006–2010).Participants 451 270 participants genetically similar to the 1000 Genomes European reference population, with a mean of 13.3-year follow-up through hospital inpatient, cancer registries and death certificate data.Main outcome measures Cox proportional HRs of incident clinical outcomes and mortality in those with HFE p.C282Y/p.H63D mutations compared with those with no variants, stratified by sex and adjusted for age, assessment centre and genetic stratification. …”
Get full text

Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011–2019 NPCR and SEER incidence data by Wei Zhang, Wei Zhang, Yuhui Bai, Caixing Sun, Caixing Sun, Zhangchun Lv, Shihua Wang

“…This study was to update the status of TNBC and the temporal changes of its incidence rate in the US.MethodsWomen diagnosed with breast cancer during 2011–2019 were obtained from the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology and End Results (SEER) Program SEER*Stat Database which covers the entire population of the US. …”
Get full text

Enhancing Self-care Among Oral Cancer Survivors: Protocol for the Empowered Survivor Trial by Sharon L Manne, Matin Imanguli, Deborah Kashy, Morgan Pesanelli, Sara Frederick, Janet H Van Cleave, Lisa Paddock, Shawna Hudson, Michael Steinberg, Patrick Clifford, Mara Domider, Neetu Singh

“…MethodsThis study will recruit a total of 600 individuals who were diagnosed with oral cavity or oropharyngeal cancer in the past 3 years and are currently cancer free primarily from state cancer registries; these individuals will be randomly assigned to either the ES or Springboard Beyond Cancer condition. …”
Get full text

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. by Rothwell, P, Fowkes, F, Belch, J, Ogawa, H, Warlow, C, Meade, T

“…In three large UK trials, long-term post-trial follow-up of individual patients was obtained from death certificates and cancer registries. RESULTS: In eight eligible trials (25 570 patients, 674 cancer deaths), allocation to aspirin reduced death due to cancer (pooled odds ratio [OR] 0·79, 95% CI 0·68-0·92, p=0·003). …”

Association of incident amelanotic melanoma with phenotypic characteristics, MC1R status, and prior amelanotic melanoma by Vernali, S, Waxweiler, W, Dillon, P, Kanetsky, P, Orlow, I, Luo, L, Busam, K, Kricker, A, Armstrong, B, Anton-Culver, H, Gruber, S, Gallagher, R, Zanetti, R, Rosso, S, Sacchetto, L, Dwyer, T, Cust, A, Ollila, D, Begg, C, Berwick, M, Thomas, N

“…</p> <h4>Design, Setting, and Participants</h4> <p>The Genes, Environment, and Melanoma (GEM) study is an international cohort study that enrolled patients with incident primary cutaneous melanomas from population-based and hospital-based cancer registries (1998 to 2003). The GEM participants included here were 2387 patients with data for phenotypes, MC1R genotype, and primary melanomas scored for histopathologic pigmentation. …”

Rising Incidence of Non-Cardia Gastric Cancer among Young Women in the United States, 2000–2018: A Time-Trend Analysis Using the USCS Database by Janice Oh, Yazan Abboud, Miguel Burch, Jun Gong, Kevin Waters, Jenan Ghaith, Yi Jiang, Kenneth Park, Quin Liu, Rabindra Watson, Simon K. Lo, Srinivas Gaddam

“…Using the same methodology, findings were then externally validated using SEER-independent data from the National Program of Cancer Registries (NPCR). Stratified analyses by race, histopathology, and staging at diagnosis were also conducted in younger adults. …”
Get full text

Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France by Kueshivi Midodji Atsou, Bernard Rachet, Edouard Cornet, Marie‐Lorraine Chretien, Cédric Rossi, Laurent Remontet, Laurent Roche, Roch Giorgi, Sophie Gauthier, Stéphanie Girard, Johann Böckle, Stéphane Kroudia Wasse, Helene Rachou, Laila Bouzid, Jean‐Marc Poncet, Sébastien Orazio, Alain Monnereau, Xavier Troussard, Morgane Mounier, Marc Maynadie

“…Methods We included 1039 AML incident cases diagnosed between 2012–2016 from the 3 French blood cancer registries (3,625,400 inhabitants). We describe patients according to age, the medical entry unit and access to the specialised haematology unit (SHU) during follow‐up. …”
Get full text

Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2− breast cancer: a propensity score-matched retrospective cohort study using the SEER database by Chao Yang, Xindi Ma, Shang Wu, Xiangmei Zhang, Nannan Chen, Chenhui Yang, Miao Cao, Kaiye Du, Yunjiang Liu

“…Objectives This study aimed to investigate the impact of adjuvant chemotherapy (ACT) on survival outcomes in older women with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2−) breast cancer (BC).Design A retrospective cohort study using data from the Surveillance, Epidemiology, and End Results database, which contains publicly available information from US cancer registries.Setting and participants The study included 45 762 older patients with BC aged over 65 years diagnosed between 2010 and 2015.Methods Patients were divided into two groups based on age: 65–79 years and ≥80 years. …”
Get full text

Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer by Anna Öfverholm, Therese Törngren, Anna Rosén, Brita Arver, Zakaria Einbeigi, Karin Haraldsson, Anne Kinhult Ståhlbom, Ekaterina Kuchinskaya, Annika Lindblom, Beatrice Melin, Ylva Paulsson-Karlsson, Marie Stenmark-Askmalm, Emma Tham, Anna von Wachenfeldt, Anders Kvist, Åke Borg, Hans Ehrencrona

“…The genetic outcome was compared with tumor characteristics and other clinical data collected from national cancer registries and hospital records. Results In 4622 women with breast and/or ovarian cancer the overall diagnostic yield (the proportion of women carrying at least one PV) was 16.6%. …”
Get full text

Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort studyResearch in... by Hongmei Zeng, Mengyuan Xu, Yingwei Xie, Sergiusz Nawrocki, Jakub Morze, Xianhui Ran, Tianhao Shan, Changfa Xia, Yixin Wang, Lingeng Lu, Xue Qin Yu, Catarina Machado Azeredo, John S. Ji, Xiaomei Yuan, Katherine Curi-Quinto, Yuexin Liu, Bingsheng Liu, Tao Wang, Hao Ping, Edward L. Giovannucci

“…Methods: In this retrospective, population-based longitudinal cohort study, we identified patients diagnosed with first primary prostate cancer between 1995 and 2019, with follow-up until Dec 31, 2019, using population-based cancer registries’ data from the Surveillance, Epidemiology, and End Results (SEER) Program. …”
Get full text

Exposure to long-term source-specific transportation noise and incident breast cancer: A pooled study of eight Nordic cohorts by Jesse D. Thacher, Anna Oudin, Erin Flanagan, Kristoffer Mattisson, Maria Albin, Nina Roswall, Andrei Pyko, Gunn Marit Aasvang, Zorana J. Andersen, Signe Borgquist, Jørgen Brandt, Karin Broberg, Thomas Cole-Hunter, Charlotta Eriksson, Kristina Eneroth, Hrafnhildur Gudjonsdottir, Emilie Helte, Matthias Ketzel, Timo Lanki, Youn-Hee Lim, Karin Leander, Petter Ljungman, Jonas Manjer, Satu Männistö, Ole Raaschou-Nielsen, Göran Pershagen, Debora Rizzuto, Malte Sandsveden, Jenny Selander, Mette K. Simonsen, Lara Stucki, Mårten Spanne, Leo Stockfelt, Anne Tjønneland, Tarja Yli-Tuomi, Pekka Tiittanen, Victor H. Valencia, Mikael Ögren, Agneta Åkesson, Mette Sørensen

“…Breast cancer incidence (all, estrogen receptor (ER) positive, and ER negative) was derived from cancer registries. Hazard ratios (HR) were estimated using Cox Proportional Hazards Models, adjusting main models for sociodemographic and lifestyle variables together with long-term exposure to air pollution. …”
Get full text

Features That Middle-aged and Older Cancer Survivors Want in Web-Based Healthy Lifestyle Interventions: Qualitative Descriptive Study by Nataliya V Ivankova, Laura Q Rogers, Ivan I Herbey, Michelle Y Martin, Maria Pisu, Dorothy Pekmezi, Lieu Thompson, Yu-Mei M Schoenberger-Godwin, Robert A Oster, Kevin Fontaine, Jami L Anderson, Kelly Kenzik, David Farrell, Wendy Demark-Wahnefried

“…MethodsUsing a qualitative descriptive approach, we conducted 10 focus groups with 57 cancer survivors recruited from hospital cancer registries in 1 southeastern US state. Data were analyzed using inductive thematic and content analyses with NVivo (version 12.5, QSR International). …”
Get full text

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. by Vos, T, Flaxman, A, Naghavi, M, Lozano, R, Michaud, C, Ezzati, M, Shibuya, K, Salomon, J, Abdalla, S, Aboyans, V, Abraham, J, Ackerman, I, Aggarwal, R, Ahn, S, Ali, M, Alvarado, M, Anderson, H, Anderson, L, Andrews, K, Atkinson, C, Baddour, L, Bahalim, A, Barker-Collo, S, Barrero, L, Bartels, D

“…Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies. …”

BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients by Manfred Wischnewsky, Lukas Schwentner, Joachim Diessner, Amelie de Gregorio, Ralf Joukhadar, Dayan Davut, Jessica Salmen, Inga Bekes, Matthias Kiesel, Max Müller-Reiter, Maria Blettner, Regine Wolters, Wolfgang Janni, Rolf Kreienberg, Achim Wöckel, Florian Ebner

“…Patients and methods Data from 10,499 patients were available from 17 clinical cancer registries (BRENDA-project. In total, 8566 were used to develop the BRENDA-Index. …”
Get full text

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study by Hippisley-Cox, J, Coupland, CA, Mehta, N, Keogh, RH, Diaz-Ordaz, K, Khunti, K, Lyons, RA, Kee, F, Sheikh, A, Rahman, S, Valabhji, J, Harrison, EM, Sellen, P, Haq, N, Semple, MG, Johnson, PWM, Hayward, A, Nguyen-Van-Tam, JS

“…</p> <p><strong>Design</strong> Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, SARS-CoV-2 results, hospital admissions, systemic anticancer treatment, radiotherapy, and the national death and cancer registries.</p> <p><strong>Settings</strong> Adults aged 19-100 years with one or two doses of covid-19 vaccination between 8 December 2020 and 15 June 2021.…”

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 by Sheena, BS, Hiebert, L, Han, H, Matthews, PC, Buendia Rodriguez, JA

“…</p> <p><strong>Methods</strong> The primary data sources were population-based serosurveys, claims and hospital discharges, cancer registries, vital registration systems, and published case series. …”

Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort studyResearch in context by Maxime Beydon, Sandrine Pinto, Yann De Rycke, Bruno Fautrel, Xavier Mariette, Raphaèle Seror, Florence Tubach

“…Methods: This is a nationwide population-based study within the French national claims database “Système National des Données de Santé” (SNDS) between January 1st 2010 and December 31st 2020, to estimate the age and sex-standardized incidence ratios of cancer (all sites and site specific) of treated rheumatoid arthritis patients, with the French population as reference (by use of the French Network of Population-Based Cancer Registries [FRANCIM]). Findings: During the study period, 257,074 treated patients with rheumatoid arthritis contributed to a total of 2,098,238 person-years for the main analysis. …”
Get full text